Skin Neoplasm
13
3
4
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.4%
2 terminated out of 13 trials
71.4%
-15.1% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
PLANNED VISUAL EDUCATION ABOUT SKIN CANCER
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
Utility of the Skin Cancer Quality of Life Impact Tool
EPR Tumor Oximetry With CE India Ink
School-based Randomized Trial of SunSmart Interventions
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma